Founded in 2003, Genzon Group is a diversified group with real estate, scientific and technological innovation and industrial investment as its core strategic track.

The real estate business of Genzon focuses on Shenzhen, deeply cultivate Guangdong-Hong Kong-Macao Greater Bay Area continuously, always takes self-sustaining high-quality properties as the core development strategy, invests in and successfully operates high-quality real estate projects with an area of more than 3 million m2, and its business covers the whole industrial chain from real estate development, construction to operation services. The industrial park serves more than 3,000 high-tech enterprises, including more than 220 national high-tech enterprises, more than 50 listed companies, and more than 300,000 employees. A number of strategic emerging industries, such as Internet, great health, financial technology, TMT, and artificial intelligence, etc. gather here, and the annual GDP of enterprises in the park exceeds 180 billion yuan.

Meanwhile, the backbone has long had a deep understanding of the industrial law and heat trend. Genzon has successfully invested in and operated several batch excellent scientific and technological innovation enterprises in emerging industries and polar layouts, such as biopharmaceutical macromolecule materials, high-end metal materials, and smart cold chain. Among them, Sinovac Biotech, a leading enterprise in China recombinant protein drug industry, has been successfully listed on the scientific and technological innovation board, Stock Code: 688136. While focusing on urban and industrial upgrading, Genzon actively expands its investment strategy track, relying on funds and venture capital, based on scientific and technological innovation, serves scientific and technological innovation, and helps industrial and financial linkage development of Genzon.